peroxynitrous acid has been researched along with dipyrromethene in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (dipyrromethene) | Trials (dipyrromethene) | Recent Studies (post-2010) (dipyrromethene) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 153 | 0 | 122 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esmaeili Mohsen Abadi, S; Imani-Nejad, M; Johns, M; Kwon, G; Lee, J; Malik, N; McPherson, T; Neumann, WL; Rausaria, S; Schober, J | 1 |
1 other study(ies) available for peroxynitrous acid and dipyrromethene
| Article | Year |
|---|---|
Oral administration of SR-110, a peroxynitrite decomposing catalyst, enhances glucose homeostasis, insulin signaling, and islet architecture in B6D2F1 mice fed a high fat diet.
Topics: Administration, Oral; Animals; Blood Glucose; Dietary Fats; Homeostasis; Insulin; Insulin-Secreting Cells; Mice; Peroxynitrous Acid; Porphobilinogen; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |